glp 1 clinical pearls GLP-1 medications are transforming healthcare and in the process have created new challenges for rehab professionals. As physical and occupational therapists, we have an important role in helping patients preserve muscle, maintain Novel oral GLP-1 receptor agonist

She denied defendants requests for judicial notice and to strike, and granted in part/denied in part defendants motion to dismiss

A pooled analysis of three major cardiovascular outcome trials (CVOTs) studying 15,820 patients with T2D treated with liraglutide or semaglutide reported a significantly lower hazard ratio ([HR] = 0.47) for subsequent dementia diagnosis compared to placebo, over a median follow-up of 3.61 years

Results guide dose escalation and help predict GI side effect risk

Portal messaging is the fastest way, and we respond the same week

S.CliffordG

Led by Anders Fink-Jensen at the University of Copenhagen, this work explored the use of exenatide